Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.
Heaney JLJ et al. Br J Haematol. 2017 Jun 1. doi: 10.1111/bjh.14753. [Epub ahead of print].

Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease.
Hofmann JN et al. Obesity (Silver Spring). 2017 Jun 11. doi: 10.1002/oby.21894. [Epub ahead of print].

Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
Lacognata C et al. Clin Radiol. 2017 Jun 3. pii: S0009-9260(17)30180-0. doi: 10.1016/j.crad.2017.05.004. [Epub ahead of print].

Prediction of outcome in newly diagnosed myeloma: A meta-analysis of the molecular profiles of 1,905 trial patients.
Shah V et al. Leukemia. 2017 Jun 6. doi: 10.1038/leu.2017.179. [Epub ahead of print].

Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients.
Espiño M et al. Bone Marrow Transplant. 2017 Jun 5. doi: 10.1038/bmt.2017.97. [Epub ahead of print].

Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
Messiaen AS et al. Am J Clin Pathol. 2017 Jun 1;147(6):611-622. doi: 10.1093/ajcp/aqx037.

Therapy assessment in multiple myeloma with PET.
Nanni C et al. Eur J Nucl Med Mol Imaging. 2017 Jun 1. doi: 10.1007/s00259-017-3730-4. [Epub ahead of print].

Quantitative MRI and spectroscopy of bone marrow.
Karampinos DC et al. J Magn Reson Imaging. 2017 Jun 1. doi: 10.1002/jmri.25769. [Epub ahead of print].

The Prognostic Significance of Polyclonal Bone Marrow Plasma Cells in Patients with Relapsing Multiple Myeloma.
Ghosh T et al. Am J Hematol. 2017 May 31. doi: 10.1002/ajh.24807. [Epub ahead of print].

High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.
Fan L e al. Med Sci Monit. 2017 May 30;23:2636-2643.

Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
Moreb JS et al. J Clin Apher. 2017 May 29. doi: 10.1002/jca.21556. [Epub ahead of print].

Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma.
Rabut É et al. Ann Biol Clin (Paris). 2017 Jun 1;75(3):351-355. doi: 10.1684/abc.2017.1237.

Interest of the combined measurement of selected urinary proteins in the diagnosis approach in nephrology.
Bastard JP et al. Ann Biol Clin (Paris). 2017 Jun 1;75(3):327-333. doi: 10.1684/abc.2017.1247.